**Strong US political, regulatory, and supply constraints make a 2026 Apple-CXMT deal unlikely despite testing and memory shortages.** Apple began qualifying CXMT DRAM in mid-2026 for potential limited use in China-market iPhones and MacBooks, driven by AI-fueled DRAM shortages that raised prices and prompted Apple price hikes on Macs and iPads. CXMT, China’s leading DRAM producer with roughly 10-11% global wafer share, offers off-the-shelf LPDDR5X and similar parts, but US rules bar custom co-design or significant tech transfer. The company sits on the Pentagon’s 1260H Chinese military companies list, triggering bipartisan Senate opposition and explicit Trump administration resistance from Commerce Secretary Howard Lutnick. CXMT’s fabs ran near 95% utilization in 2026 with output largely pre-allocated to domestic buyers such as Huawei, Xiaomi, and ByteDance through at least 2027, leaving minimal capacity for new international customers. Reported pricing has been comparable to or above Samsung, SK hynix, and Micron levels, removing the cost incentive. While HP and Acer have used CXMT parts in some non-US laptops, Apple has not announced any purchase or supply agreement as of late October 2026, and new CEO John Ternus has only kept options open without committing. These barriers—regulatory approval uncertainty, capacity limits, and export restrictions—explain trader consensus favoring “No” at 79.5% implied probability. Key near-term catalysts include any White House policy shift or confirmed qualification results, but year-end timing reduces the chance of meaningful 2026 volume.